menu
    • menu

    Company profile for AB Science

    NEW Drugs in Dev: 5
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AB Science was founded in 2001 by a team of scientists in order to develop new drugs targeting indications with unmet medical needs, in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. In human medicine, our masitinib pipeline is well advanced with several phase 3 studies in oncology and non-oncology diseases and promising data in Amyotrophic Lateral Sclerosis and indolent severe sys...
    AB Science was founded in 2001 by a team of scientists in order to develop new drugs targeting indications with unmet medical needs, in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. In human medicine, our masitinib pipeline is well advanced with several phase 3 studies in oncology and non-oncology diseases and promising data in Amyotrophic Lateral Sclerosis and indolent severe systemic mastocytosis. Masitinib is already commercialized in veterinary medicine and we celebrated in 2018 the 10th anniversary of the EMA marketing authorization of our product Masivet.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AB ScienceFrance Flag
    Country
    Country
    France
    Address
    Address
    3, Avenue George V 75008 PARIS
    Telephone
    Telephone
    +33 (0)1 47 20 00 14
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ab-science.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AB Science Secures US Patent for Masitinib in Metastatic Melanoma
    AB Science Secures US Patent for Masitinib in Metastatic Melanoma

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3228942/0/en/AB-Science-receives-notice-of-allowance-for-US-patent-covering-masitinib-in-the-treatment-of-metastatic-castrate-resistant-prostate-cancer.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    AB Science Secures Masitinib Patent for Progressive MS in Japan
    AB Science Secures Masitinib Patent for Progressive MS in Japan

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3223115/0/en/AB-Science-receives-Japanese-patent-protection-for-the-use-of-masitinib-in-progressive-forms-of-multiple-sclerosis-MS-until-2041.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    AB Science Sees 4th Positive Response In Ab8939-Venetoclax Combo
    AB Science Sees 4th Positive Response In Ab8939-Venetoclax Combo

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214817/0/en/AB-Science-reports-fourth-consecutive-case-of-response-from-Phase-1-data-for-the-combination-of-AB8939-with-venetoclax-for-the-treatment-of-refractory-or-relapsed-acute-myeloid-leu.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    AB Science Secures US Patent For Masitinib In Sickle Cell
    AB Science Secures US Patent For Masitinib In Sickle Cell

    27 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/ab-science-secures-us-patent-for-masitinib-in-sickle-cell-disease-till-2040-18698

    INDPHARMAPOST
    27 Dec 2025
    Share Share
    Ab Science Announces Initiation of Coverage of Stock
    Ab Science Announces Initiation of Coverage of Stock

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3208083/0/en/AB-Science-announces-the-initiation-of-coverage-of-its-stock-by-Maxim-Group-with-a-target-price-of-EUR-4-0-per-share.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    AB Science Unveils BioRxiv Paper on AB8939 for Refractory AML
    AB Science Unveils BioRxiv Paper on AB8939 for Refractory AML

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205726/0/en/AB-Science-announces-a-new-publication-on-biorxiv-that-identifies-AB8939-as-a-promising-drug-candidate-for-treating-refractory-acute-myeloid-leukemia-and-potentially-other-cancers.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search